New preprint showcases results in an ALS mouse model
Miramoon Pharma's pipeline targets many disorders and we are very happy to report the results of a research study in which one of our drug candidates, MP-010, was tested in an amyotrophic lateral sclerosis mouse model to see if it could improve motor function and